Kim Sapsford

Dr. Kim Sapsford


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2011 in Analytical Chemistry
Verified
Journal Article
Closed access
KSKim Sapsford
Kim Sapsford
KTKatherine M. Tyner
Katherine M. Tyner
BDBenita J. Dair
Benita J. Dair
JDJeffrey Deschamps
Jeffrey Deschamps
IMIgor L. Medintz
Igor L. Medintz

28 February 2011 in ACS Nano
Verified
Journal Article
Closed access
KSKim Sapsford
Kim Sapsford
JGJessica Granek
Jessica Granek
JDJeffrey Deschamps
Jeffrey Deschamps
KBKelly Boeneman
Kelly Boeneman
JBJuan Bautista Blanco-Canosa
Juan Bautista Blanco-Canosa
Igor MedintzIgor Medintz
Igor Medintz

25 November 2014 in Sensors
Verified
Journal Article
Open access
PDF file
SSSamantha Spindel
Samantha Spindel
KSKim Sapsford
Kim Sapsford
This review investigates optical sensor platforms for protein multiplexing, the ability to analyze multiple analytes simultaneously. Multiplexing is becoming increasingly important for clinical needs because disease and therapeutic response often involve the interplay between a variety of complex biological networks encompassing multiple, rather than single, proteins. Multiplexing is generally achieved through one of two routes, either through spatial separation on a surface (different wells or spots) or with the use of unique identifiers/labels (such as spectral separation—different colored dyes, or unique beads—size or color). The strengths and weaknesses of conventional platforms such as immunoassays and new platforms involving protein arrays and lab-on-a-chip technology, including commercially-available devices, are discussed. Three major public health concerns are identified whereby detecting medically-relevant markers using Point-of-Care (POC) multiplex assays could potentially allow for a more efficient diagnosis and treatment of diseases.

16 June 2011 in Sensors
Verified
Journal Article
Open access
PDF file
MKMichele D. Kattke
Michele D. Kattke
EGElizabeth Gao
Elizabeth Gao
KSKim Sapsford
Kim Sapsford
LSLarry D. Stephenson
Larry D. Stephenson
AKAshok Kumar
Ashok Kumar
In this study, a fluorescence resonance energy transfer (FRET)-based quantum dot (QD) immunoassay for detection and identification of Aspergillus amstelodami was developed. Biosensors were formed by conjugating QDs to IgG antibodies and incubating with quencher-labeled analytes; QD energy was transferred to the quencher species through FRET, resulting in diminished fluorescence from the QD donor. During a detection event, quencher-labeled analytes are displaced by higher affinity target analytes, creating a detectable fluorescence signal increase from the QD donor. Conjugation and the resulting antibody:QD ratios were characterized with UV-Vis spectroscopy and QuantiT protein assay. The sensitivity of initial fluorescence experiments was compromised by inherent autofluorescence of mold spores, which produced low signal-to-noise and inconsistent readings. Therefore, excitation wavelength, QD, and quencher were adjusted to provide optimal signal-to-noise over spore background. Affinities of anti-Aspergillus antibody for different mold species were estimated with sandwich immunoassays, which identified A. fumigatus and A. amstelodami for use as quencher-labeled- and target-analytes, respectively. The optimized displacement immunoassay detected A. amstelodami concentrations as low as 103 spores/mL in five minutes or less. Additionally, baseline fluorescence was produced in the presence of 105 CFU/mL heat-killed E. coli O157:H7, demonstrating high specificity. This sensing modality may be useful for identification and detection of other biological threat agents, pending identification of suitable antibodies. Overall, these FRET-based QD-antibody biosensors represent a significant advancement in detection capabilities, offering sensitive and reliable detection of targets with applications in areas from biological terrorism defense to clinical analysis.

8 July 2014 in Sensors
Verified
Journal Article
Open access
PDF file
MAMamdouh Aloraefy
Mamdouh Aloraefy
JPJoshua Pfefer
Joshua Pfefer
Jessica RamellaJessica Ramella
Jessica Ramella
KSKim Sapsford
Kim Sapsford
Rapid, accurate, and minimally-invasive glucose biosensors based on Förster Resonance Energy Transfer (FRET) for glucose measurement have the potential to enhance diabetes control. However, a standard set of in vitro approaches for evaluating optical glucose biosensor response under controlled conditions would facilitate technological innovation and clinical translation. Towards this end, we have identified key characteristics and response test methods, fabricated FRET-based glucose biosensors, and characterized biosensor performance using these test methods. The biosensors were based on competitive binding between dextran and glucose to concanavalin A and incorporated long-wavelength fluorescence dye pairs. Testing characteristics included spectral response, linearity, sensitivity, limit of detection, kinetic response, reversibility, stability, precision, and accuracy. The biosensor demonstrated a fluorescence change of 45% in the presence of 400 mg/dL glucose, a mean absolute relative difference of less than 11%, a limit of detection of 25 mg/dL, a response time of 15 min, and a decay in fluorescence intensity of 72% over 30 days. The battery of tests presented here for objective, quantitative in vitro evaluation of FRET glucose biosensors performance have the potential to form the basis of future consensus standards. By implementing these test methods for a long-visible-wavelength biosensor, we were able to demonstrate strengths and weaknesses with a new level of thoroughness and rigor.

11 August 2011 in Sensors
Verified
Journal Article
Open access
PDF file
KSKim Sapsford
Kim Sapsford
SSSamantha Spindel
Samantha Spindel
TJTravis Jennings
Travis Jennings
GTGuoliang Tao
Guoliang Tao
RTRobert C. Triulzi
Robert C. Triulzi
Igor MedintzIgor Medintz
Igor Medintz
The simultaneous detection of two analytes, chicken IgY (IgG) and Staphylococcal enterotoxin B (SEB), in the single well of a 96-well plate is demonstrated using luminescent semiconductor quantum dot nanocrystal (NC) tracers. The NC-labeled antibodies were prepared via sulfhydryl-reactive chemistry using a facile protocol that took